Evidence map›Paper›PMID 42663330›Full record

ArticleCancer2026

Reply to "Does disease ontogeny matter more than JAK2 mutation status in acute myeloid leukemia?"

Moath Albliwi, Daniel P Nurse, Emily C Zabor, John Hanna, Jessica El-Asmar, Ameed Bawwab, Hasan Abuamsha, Yomna Abu-Farsakh, Heya Batah, Asad Rauf and 13 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Moath AlbliwiDepartment of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.ORCID https://orcid.org/0009-0003-1914-0054
Daniel P NurseDepartment of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Emily C ZaborDepartment of Quantitative Health Sciences, Cleveland Clinic Research, Cleveland, Ohio, USA.
John HannaDepartment of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Jessica El-AsmarDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
Ameed BawwabDepartment of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Hasan AbuamshaDepartment of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Yomna Abu-FarsakhDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
Heya BatahDepartment of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Asad RaufDepartment of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
Joy NakitandweDepartment of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, Ohio, USA.
David S BoslerDepartment of Pathology and Laboratory Medicine, Cleveland Clinic Diagnostics Institute, Cleveland, Ohio, USA.
Prerana Bangalore ParthasarathyDepartment of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
Tyler AlbanDepartment of Cancer Sciences and Center for Immunotherapy and Precision Immuno-Oncology, Cleveland Clinic, Cleveland, Ohio, USA.
Akriti G JainDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0002-7238-9241
John C MolinaDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
Sophia BaldermanDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
Abhay SinghDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
Aaron T GerdsDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
Sudipto MukherjeeDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
Anjali S AdvaniDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
Hetty E CarrawayDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.
Moaath K Mustafa AliDepartment of Hematology and Medical Oncology, Cleveland Clinic Taussig Cancer Institute, Cleveland, Ohio, USA.ORCID https://orcid.org/0000-0003-3289-2333

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42663330
PMCPMC13523622

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.